Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > About JDRF & our impact > Our research > Information for researchers > How to apply for a JDRF grant
All JDRF grants are reviewed and awarded through our centralised Grant Center in the US, except for our UK-specific research funding opportunities and those we fund in partnership with other organisations.
We use the research management system, RMS360, to receive, process and track applications for JDRF funding. You can apply for a grant by registering for an RMS360 account. You will then find the ‘Apply Now’ button under the ‘Funding Opportunities’ section of RMS360 homepage.
First, take a look at our FAQs about how to use RMS360 which contains screenshots to help you resolve your issues.
If you have questions about our grants or administration process, please contact JDRF’s Scientific and Grant Administration staff. If you are still experiencing difficulties, please email email@example.com
As a member of the Association of Medical Research Charities (AMRC), JDRF are eligible for the Charity Research Support Fund (CRSF). The CRSF is a pot of government funding given to universities to cover the indirect costs of research, such as the administration overheads, library costs, and shared IT.
The CRSF supports our investment in university research across England, and equivalent schemes exist in each of the devolved nations. The Scottish Funding Council provides charity support via its Research Excellence Grant for universities in Scotland. The Higher Education Funding Council for Wales supports university research through their Quality Research funding stream. The Department for the Economy in Northern Ireland administers funding for university research through their Dual Support System taking place in universities there.
If you want to know more about the scheme, the AMRC has some helpful FAQs about the CSRF.
We only fund research that is directly relevant to our research strategy to improve lives and cure type 1 diabetes. Find out more about JDRF’s research strategy to ensure that your application fits our mission and current priorities.
We always consider the quality and relevance of the proposed research to people with type 1 when making our funding decisions. We encourage researchers to submit innovative, high-risk/high-reward, field-changing research proposals to accelerate our mission.
First, our scientific and administrative staff carry out an admin check. They ensure the application is complete, meets JDRF requirements, and aligns with our overall strategy. Upon request, we can provide feedback at this stage on whether your application has progressed.
Next, the proposal moves to stage 1 of the review process where the Core Program Team (CPT), made of scientists focused on the project’s research area, reviews the application. The CPTs call on external reviewers – meaning they are independent of JDRF – to advise them on most applications. The external reviewers and CPTs assess the research proposal based on its scientific validity, technical feasibility, innovation and timescale. They also consider the significance of the research funding application. This includes the project’s potential impact on type 1 diabetes treatments, how it is relevant to people with type 1, and whether it addresses a critical gap in our understanding of the condition.
Stage 2 of the review process involves the Cure/Improving Lives senior management team assessing the research proposal. This team comprises JDRF’s entire research department, who prioritise projects that can be developed into real therapies fastest. The team also considers how relevant the research is to our overall goals, specific research priorities and our existing project portfolio.
If the application reaches stage 3, we make a final decision on whether we will fund it. For projects with smaller budgets, this decision rests with the JDRF Chief Scientific Officer Dr Sanjoy Dutta. For all other projects, the executive research committee of JDRF’s International Board of Directors, who are mostly lay people, make the decision.
JDRF has passed the AMRC Peer Review Audit, a hallmark of quality research funding.
Grants funded by JDRF UK directly follow a different assessment process. Read more about the JDRF UK Small Grant Awards.
For the approval of the grants we offer in partnership with other organisations, we work with the partners throughout the process. The final decision is agreed through JDRF’s governance processes.
Find out more about the current funding opportunities we have available for UK projects.
Browse what we offer, including grant opportunities, access to research resources to support your project, and help with patient participation.
From accessing to data and biological samples to involving people with type 1 in your research, find out how we can help with your project.